GlassScriptPhysician profile
Lisa M Ewan
NPI 1093087249
$7,884.12
in general payments reported to CMS, 2019-2025
28 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,439 · 2022: $1,588 · 2023: $2,234 · 2024: $2,238 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,778 · Education: $79.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,777.83 |
| Education | $79.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,580.16 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,086.60 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $1,033.41 | 2021-2024 | Rexulti, Abilify Maintena, Nuedexta |
| Lundbeck LLC | $559.41 | 2021-2024 | Rexulti |
| Tris Pharma INC | $424.85 | 2021-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $403.58 | 2021-2024 | Trintellix |
| Alkermes, INC. | $373.88 | 2021-2024 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $348.97 | 2022-2024 | Austedo Xr, Austedo, Uzedy |
| Axsome Therapeutics, INC. | $317.77 | 2024-2025 | Auvelity |
| Bausch Health US, LLC | $265.91 | 2021-2024 | Aplenzin, Wellbutrin |
| Neos Therapeutics, LP | $166.43 | 2021-2024 | Adzenys Xr-Odt |
| Avanir Pharmaceuticals, INC. | $132.98 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $131.40 | 2021-2024 | Ingrezza |
| Almatica Pharma LLC | $126.14 | 2023-2024 | Loreev Xr, Gralise, Sertraline Hcl |
| Corium, LLC | $125.07 | 2022-2024 | Azstarys |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $123.26 | 2022-2023 | Hetlioz, Fanapt |
| Sunovion Pharmaceuticals INC. | $116.89 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $99.42 | 2024-2025 | Cobenfy |
| Adlon Therapeutics L.P. | $83.48 | 2021 | |
| Ironshore Pharmaceuticals INC. | $80.72 | 2023-2024 | Jornay Pm |
| Tempus Ai, INC | $68.95 | 2024 | |
| Merck Sharp & Dohme LLC | $66.56 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $43.34 | 2023-2024 | Spravato, Invega |
| Eisai INC. | $40.21 | 2021 | |
| Sage Therapeutics, LLC | $28.73 | 2024 | |
| Noven Therapeutics, LLC | $26.01 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $15.88 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Ewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.